【ChiCTR2000034588】An observational cohort study to evaluate volume and severity of emergency general surgery admissions during the COVID-19 pandemic: is there a “lockdown” effect?
ChiCTR2000034588
结束
/
/
/
2020-07-11
/
/
新型冠状病毒肺炎(COVID-19)
An observational cohort study to evaluate volume and severity of emergency general surgery admissions during the COVID-19 pandemic: is there a “lockdown” effect?
An observational cohort study to evaluate volume and severity of emergency general surgery admissions during the COVID-19 pandemic: is there a “lockdown” effect?
The aim of this study was to investigate the impact of the UK Governments lockdown’ on the volume and severity of surgical admissions during the COVID-19 pandemic by evaluating changes in the aetiology of presentations, management approach and short-term outcomes for these patients. These observations may be utilised to inform future surgical practice during subsequent COVID-19 surges locally and may help to inform surgical decisions across the NHS.
连续入组
回顾性研究
No randomisation
N/A
Nil
/
207
/
2020-02-16
2020-05-15
/
The main inclusion criteria were any adult (≥16 years old) patients who were admitted for more than 24 hours requiring specialist general surgical assessment and treatment or referred from another specialty requiring the same.;
请登录查看Patients were excluded from the study if they were admitted and transferred to urological services, admitted for less than 24 hours, or under 16 years of age.;
请登录查看英格兰北部蒂斯大学医院
/
英格兰北部蒂斯大学医院的其他临床试验
联合王国英格兰北部蒂斯大学医院的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

